Wockhardt

This study tested a new antibiotic combination, cefepime-zidebactam, against a standard antibiotic (meropenem) in adults hospitalized with complicated urinary tract infections or kidney infections. About 530 participants received either the new drug or the standard one for 7 to 1…

This completed Phase 1 study looked at how healthy men process and eliminate the antibiotic zidebactam. Eight participants received a single dose with a radioactive tracer to track the drug in urine and feces. The goal was to understand how the drug is broken down and how quickly…

This early-stage trial tested the safety and tolerability of multiple intravenous doses of zidebactam, an experimental antibiotic, in 21 healthy adults. Participants received either the drug or a placebo, and researchers monitored for side effects, vital signs, and lab results. T…

This early-stage study tested the safety and how the body processes two antibiotics—Zidebactam-Cefepime and Metronidazole—given alone or together. Thirty healthy adults received single doses in three different sequences. The goal was to measure drug levels and check for side effe…